Bone marrow-derived angiogenic cells restore lung alveolar and vascular structure after neonatal hyperoxia in infant mice
- 1 March 2010
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 298 (3), L315-L323
- https://doi.org/10.1152/ajplung.00089.2009
Abstract
Neonatal hyperoxia impairs vascular and alveolar growth in mice and decreases endothelial progenitor cells. To determine the role of bone marrow-derived cells in restoration of neonatal lung structure after injury, we studied a novel bone marrow myeloid progenitor cell population from Tie2-green fluorescent protein (GFP) transgenic mice (bone marrow-derived angiogenic cells; BMDAC). We hypothesized that treatment with BMDAC would restore normal lung structure in infant mice during recovery from neonatal hyperoxia. Neonatal mice (1-day-old) were exposed to 80% oxygen for 10 days. BMDACs (1 × 105), embryonic endothelial progenitor cells, mouse embryonic fibroblasts (control), or saline were then injected into the pulmonary circulation. At 21 days of age, saline-treated mice had enlarged alveoli, reduced septation, and a reduction in vascular density. In contrast, mice treated with BMDAC had complete restoration of lung structure that was indistinguishable from room air controls. BMDAC comprised 12% of distal lung cells localized to pulmonary vessels or alveolar type II (AT2) cells and persist (8.8%) for 8 wk postinjection. Coculture of AT2 cells or lung endothelial cells (luEC) with BMDAC augmented AT2 and luEC cell growth in vitro. We conclude that treatment with BMDAC after neonatal hyperoxia restores lung structure in this model of bronchopulmonary dysplasia.This publication has 68 references indexed in Scilit:
- The roles of mesenchymal stem cells (MSCs) therapy in ischemic heart diseasesBiochemical and Biophysical Research Communications, 2007
- Recombinant human VEGF treatment transiently increases lung edema but enhances lung structure after neonatal hyperoxiaAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2006
- Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principalsBlood, 2006
- Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapyEuropean Journal of Cancer, 2006
- Monocyte and macrophage heterogeneityNature Reviews Immunology, 2005
- Basal Cells Are a Multipotent Progenitor Capable of Renewing the Bronchial EpitheliumThe American Journal of Pathology, 2004
- Little Evidence for Developmental Plasticity of Adult Hematopoietic Stem CellsScience, 2002
- Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem CellCell, 2001
- Alteration of Pulmonary Neuroendocrine Cells during Epithelial Repair of Naphthalene-Induced Airway InjuryThe American Journal of Pathology, 2000
- Hyperoxic inhibition of newborn rat lung development: Protection by deferoxamineFree Radical Biology & Medicine, 1991